Ceapro Inc Performance
| CRPOFDelisted Stock | USD 5.93 0.21 3.67% |
The firm shows a Beta (market volatility) of -9.46, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ceapro are expected to decrease by larger amounts. On the other hand, during market turmoil, Ceapro is expected to outperform it. Ceapro Inc right now shows a risk of 0.0%. Please confirm Ceapro Inc potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Ceapro Inc will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ceapro Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ceapro is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5.4 M | |
| Total Cashflows From Investing Activities | -790.7 K | |
| Free Cash Flow | 2.8 M |
Ceapro |
Ceapro Relative Risk vs. Return Landscape
If you would invest 593.00 in Ceapro Inc on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Ceapro Inc or generate 0.0% return on investment over 90 days. Ceapro Inc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Ceapro, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ceapro Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ceapro's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Ceapro Inc, and traders can use it to determine the average amount a Ceapro's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CRPOF |
Based on monthly moving average Ceapro is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ceapro by adding Ceapro to a well-diversified portfolio.
Ceapro Fundamentals Growth
Ceapro OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Ceapro, and Ceapro fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ceapro OTC Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 30.26 M | |||
| Shares Outstanding | 78.22 M | |||
| Price To Earning | 31.90 X | |||
| Price To Book | 1.70 X | |||
| Price To Sales | 1.89 X | |||
| Revenue | 17.2 M | |||
| EBITDA | 4.65 M | |||
| Cash And Equivalents | 11.37 M | |||
| Cash Per Share | 0.14 X | |||
| Total Debt | 2.51 M | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 0.41 X | |||
| Cash Flow From Operations | 3.51 M | |||
| Earnings Per Share | 0.05 X | |||
| Total Asset | 30.53 M | |||
About Ceapro Performance
By analyzing Ceapro's fundamental ratios, stakeholders can gain valuable insights into Ceapro's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ceapro has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ceapro has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. CEAPRO INC is traded on OTC Exchange in the United States.Things to note about Ceapro Inc performance evaluation
Checking the ongoing alerts about Ceapro for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Ceapro Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ceapro Inc is not yet fully synchronised with the market data | |
| Ceapro Inc has a very high chance of going through financial distress in the upcoming years |
- Analyzing Ceapro's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ceapro's stock is overvalued or undervalued compared to its peers.
- Examining Ceapro's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ceapro's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ceapro's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Ceapro's otc stock. These opinions can provide insight into Ceapro's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Ceapro OTC Stock
If you are still planning to invest in Ceapro Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ceapro's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |